0000874015-14-000026.txt : 20140124 0000874015-14-000026.hdr.sgml : 20140124 20140124200740 ACCESSION NUMBER: 0000874015-14-000026 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20140122 FILED AS OF DATE: 20140124 DATE AS OF CHANGE: 20140124 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ISIS PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000874015 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 330336973 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2855 GAZELLE COURT CITY: CARLSBAD STATE: CA ZIP: 92010 BUSINESS PHONE: 7609319200 MAIL ADDRESS: STREET 1: 2855 GAZELLE COURT CITY: CARLSBAD STATE: CA ZIP: 92010 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Geary Richard S CENTRAL INDEX KEY: 0001442730 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19125 FILM NUMBER: 14547234 MAIL ADDRESS: STREET 1: C/O ISIS PHARMACEUTICALS, INC. STREET 2: 2855 GAZELLE COURT CITY: CARLSBAD STATE: CA ZIP: 92010 4 1 edgar.xml PRIMARY DOCUMENT X0306 4 2014-01-22 0000874015 ISIS PHARMACEUTICALS INC ISIS 0001442730 Geary Richard S C/O ISIS PHARMACEUTICALS, INC. 2855 GAZELLE COURT CARLSBAD CA 92010 0 1 0 0 SVP, Development Common Stock 2014-01-22 2014-01-22 4 M 0 8300 14.69 A 13255 D Common Stock 2014-01-22 2014-01-22 4 S 0 8300 50.046 D 4955 D Common Stock 2014-01-22 2014-01-22 4 M 0 13900 7.25 A 18855 D Common Stock 2014-01-22 2014-01-22 4 S 0 13900 50.046 D 4955 D Employee Stock Option (right to buy) 14.69 2014-01-22 2014-01-22 4 M 0 8300 0 D 2014-01-02 2020-01-29 Common Stock 8300 25240 D Employee Stock Option (right to buy) 7.25 2014-01-22 2014-01-22 4 M 0 13900 0 D 2016-01-03 2019-01-02 Common Stock 13900 14035 D Acquired as a result of exercising a stock option pursuant to a Rule 10b5-1 Trading Plan. The purchase and sale reported on this Form 4 was effective pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on 12/5/13. Grant of 1/30/13 to reporting person of stock options under the Isis Pharmaceuticals, Inc. 1989 Stock Option Plan. 25% of the shares subject to the option vested and became exercisable on 1/2/14. Thereafter, the remaining shares subject to the option vest and become exercisable in 36 equal monthly installments, at the rate of 8,385 shares per year. The option shall be fully vested and exercisable on 1/2/17. The option was exercisable as to 8,385 shares on 1/22/14. Grant of 1/3/12 to reporting person of stock options under the Isis Pharmaceuticals, Inc. 1989 Stock Option Plan. 25% of the shares subject to the option vested and became exercisable on 1/3/13. Thereafter, the remaining shares subject to the option vest and become exercisable in 36 equal monthly installments, at the rate of 6,984 shares per year. The option shall be fully vested and exercisable on 1/3/16. The option was exercisable as to 13,968 shares on 1/22/14. /s/B. Lynne Parshall, Attorney-in-Fact 2014-01-24